Since this is a new delivery platform of existing drugs rather than a new drug, the regulatory bodies in many jurisdictions typically have alternative, shorter approval pathways available to drug sponsors that do not require the standard Phase I-III clinical trials for a new drug application
Fei Y, Wang Y, Pang Y et al (2020) Xylooligosaccharide Modulates gut microbiota and alleviates colonic inflammation caused by high fat diet induced obesity
Glutathione supports: Liver detox pathways Removal of toxins Better metabolism of pollutants and heavy metals Less oxidative load on the body When the internal system is cleaner, the skin naturally looks healthier and clearer
Optimal Timing for AOD-9604 Administration Timing of AOD-9604 administration significantly impacts lipolytic efficacy
Jiao P, Wang Y, Ren G, Chu D, Li Y, Sang T (2023) Integrating network pharmacology and experimental validation to elucidate the mechanism of Yiqi Yangyin decoction in suppressing non-small-cell lung cancer
The key is knowing what to change, and when